Sign in
4

Changes in Ownership

DEXCOM INC Filed Acc 0001093557-22-000053

Chairman, CEO & President returned 9,985 shares (to the company)

  • Chairman, CEO & President acquired 16,251 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SAYER KEVIN R Chairman, CEO & President 2022-03-08 Grant or award +16,251 $0.00 $16 110,868 D: show line 1 in the form
SAYER KEVIN R Chairman, CEO & President 2022-03-09 Returned to the company −3,149 $406.06 $1,278,673 107,719 D: show line 2 in the form
SAYER KEVIN R Chairman, CEO & President 2022-03-09 Returned to the company −4,473 $406.06 $1,816,292 103,246 D: show line 3 in the form
SAYER KEVIN R Chairman, CEO & President 2022-03-09 Returned to the company −2,363 $406.06 $959,512 100,883 D: show line 4 in the form
Loading xslF345X03/edgardoc.xml…